DRW Securities’s Traws Pharma TRAW Stock Holding History

DRW Securities’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-27	Closed	-$61K	–	100
2018 Q2	$61K	Buy	+27	New	+$78.4K	﹤0.01%	96

Other funds holding TRAW

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

DRW Securities's TRAW Position: Q3 2018 in Review

DRW Securities sold out of Traws Pharma (TRAW) in Q3 2018, closing a stake of 27 shares — an estimated $61K sold.

DRW Securities first reported a position in TRAW in Q2 2018 and held it in 1 quarter. The position peaked at $61K in Q2 2018. 13 funds tracked by Wall St. Rank hold TRAW as of Q3 2018.

DRW Securities reported no remaining Traws Pharma position as of Q3 2018 after selling out during the quarter.
DRW Securities sold 27 Traws Pharma shares in Q3 2018, an estimated $61K.
DRW Securities first reported a position in Traws Pharma in Q2 2018 and held it in 1 quarter.
DRW Securities's Traws Pharma position peaked at $61K in Q2 2018.
13 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2018.

Based on DRW Securities's 13F filing for Q3 2018, filed 14 Nov 2018.